Menstrual management and reproductive concerns in adolescent and young adult women with underlying hematologic or oncologic disease
Autor: | Jennifer Louis-Jacques, Sheila M. Quinn |
---|---|
Rok vydání: | 2016 |
Předmět: |
Infertility
medicine.medical_specialty Adolescent MEDLINE Directive Counseling Disease Malignancy Young Adult 03 medical and health sciences 0302 clinical medicine Quality of life (healthcare) medicine Humans Fertility preservation Young adult Intensive care medicine Menorrhagia Referral and Consultation 030219 obstetrics & reproductive medicine business.industry Fertility Preservation Blood Coagulation Disorders medicine.disease Contraception 030220 oncology & carcinogenesis Pediatrics Perinatology and Child Health Quality of Life Physical therapy Women's Health Female Reproductive Health Services business Infertility Female Urogenital Neoplasms |
Zdroj: | Current Opinion in Pediatrics. 28:421-427 |
ISSN: | 1040-8703 |
DOI: | 10.1097/mop.0000000000000359 |
Popis: | Purpose of review Heavy menstrual bleeding is common among adolescent and young adult women, and can affect health-related quality of life. The cause of heavy menstrual bleeding is not uncommonly because of an underlying hematologic or oncologic disease process, which substantially influences the way patients are counseled and treated. Recent findings Options for menstrual management are more numerous today than ever before and range from minimizing monthly blood loss to suppressing the cycle altogether. However, an underlying bleeding disorder or malignancy can introduce many nuances and limits in individual patient care, which this review highlights. Additionally, because survival rates for adolescent and young adult cancers are improving, more of these patients are planning for lives after their disease, which may include starting or adding to a family. Options for fertility preservation during cancer therapy regimens are solidifying and both primary practitioners and subspecialists should be aware of the possibilities. Summary Patients with underlying hematologic or oncologic disease require management of menstrual bleeding, but also deserve a comprehensive evaluation and counseling regarding their individualized contraceptive needs and fertility preservation options during their reproductive years. This review employs the latest evidence from current literature to help guide clinicians caring for this unique demographic. |
Databáze: | OpenAIRE |
Externí odkaz: |